128 related articles for article (PubMed ID: 17944865)
21. Dopamine acutely decreases type 3 Na(+)/H(+) exchanger activity in renal OK cells through the activation of protein kinases A and C signalling cascades.
Gomes P; Soares-da-Silva P
Eur J Pharmacol; 2004 Mar; 488(1-3):51-9. PubMed ID: 15044035
[TBL] [Abstract][Full Text] [Related]
22. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling.
Sarantis K; Matsokis N; Angelatou F
Neuroscience; 2009 Nov; 163(4):1135-45. PubMed ID: 19647050
[TBL] [Abstract][Full Text] [Related]
23. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
Kimmel HL; Joyce AR; Carroll FI; Kuhar MJ
J Pharmacol Exp Ther; 2001 Jul; 298(1):129-40. PubMed ID: 11408534
[TBL] [Abstract][Full Text] [Related]
24. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
Kosten TA; Zhang XY; Kehoe P
J Pharmacol Exp Ther; 2005 Aug; 314(2):661-7. PubMed ID: 15845857
[TBL] [Abstract][Full Text] [Related]
25. A vehicle injection into the right core of the nucleus accumbens both reverses the region-specificity and alters the type of contralateral turning elicited by unilateral stimulation of dopamine D2/D3 and D1 receptors in the left core of the nucleus accumbens.
Ikeda H; Kotani A; Koshikawa N; Cools AR
Eur J Pharmacol; 2007 Dec; 577(1-3):64-70. PubMed ID: 17884038
[TBL] [Abstract][Full Text] [Related]
26. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
[TBL] [Abstract][Full Text] [Related]
27. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
28. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
Tidey JW; Bergman J
J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
[TBL] [Abstract][Full Text] [Related]
29. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
Pierce RC; Kalivas PW
J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128
[TBL] [Abstract][Full Text] [Related]
30. Nicotine and ethanol activate protein kinase A synergistically via G(i) betagamma subunits in nucleus accumbens/ventral tegmental cocultures: the role of dopamine D(1)/D(2) and adenosine A(2A) receptors.
Inoue Y; Yao L; Hopf FW; Fan P; Jiang Z; Bonci A; Diamond I
J Pharmacol Exp Ther; 2007 Jul; 322(1):23-9. PubMed ID: 17468300
[TBL] [Abstract][Full Text] [Related]
31. GABAA receptors in VTA mediate the morphine-induced release of ascorbic acid in rat nucleus accumbens.
Sun JY; Yang JY; Wang F; Hou Y; Dong YX; Wu CF
Brain Res; 2011 Jan; 1368():52-8. PubMed ID: 20965157
[TBL] [Abstract][Full Text] [Related]
32. Activation of phosphatidylinositol-linked D1-like receptors increases spontaneous glutamate release in rat somatosensory cortical neurons in vitro.
Chu HY; Yang Z; Zhao B; Jin GZ; Hu GY; Zhen X
Brain Res; 2010 Jul; 1343():20-7. PubMed ID: 20420815
[TBL] [Abstract][Full Text] [Related]
33. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?
Isacson R; Kull B; Wahlestedt C; Salmi P
Neuroscience; 2004; 124(1):33-42. PubMed ID: 14960337
[TBL] [Abstract][Full Text] [Related]
34. Effects of dopaminergic agents on antinociception in formalin test.
Zarrindast MR; Nassiri-Rad S; Pazouki M
Gen Pharmacol; 1999 Apr; 32(4):517-22. PubMed ID: 10323495
[TBL] [Abstract][Full Text] [Related]
35. Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway.
Zhao W; Huang Y; Liu Z; Cao BB; Peng YP; Qiu YH
PLoS One; 2013; 8(6):e65860. PubMed ID: 23799052
[TBL] [Abstract][Full Text] [Related]
36. The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release.
Nagai T; Yamada K; Yoshimura M; Ishikawa K; Miyamoto Y; Hashimoto K; Noda Y; Nitta A; Nabeshima T
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3650-5. PubMed ID: 14988509
[TBL] [Abstract][Full Text] [Related]
37. [Regulation by tissue plasminogen activator of rewarding effects of drugs of abuse].
Nagai T; Takuma K; Nabeshima T; Yamada K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):1-6. PubMed ID: 18411702
[TBL] [Abstract][Full Text] [Related]
38. Nucleus accumbens dopamine D₁ receptors regulate the expression of ethanol-induced behavioural sensitization.
Abrahao KP; Quadros IM; Souza-Formigoni ML
Int J Neuropsychopharmacol; 2011 Mar; 14(2):175-85. PubMed ID: 20426882
[TBL] [Abstract][Full Text] [Related]
39. The ameliorative effects and underlying mechanisms of dopamine D1-like receptor agonist SKF38393 on Aβ
Zang X; Cheng ZY; Sun Y; Hua N; Zhu LH; He L
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():250-261. PubMed ID: 28939187
[TBL] [Abstract][Full Text] [Related]
40. The rewards of nicotine: regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1.
Nagai T; Ito M; Nakamichi N; Mizoguchi H; Kamei H; Fukakusa A; Nabeshima T; Takuma K; Yamada K
J Neurosci; 2006 Nov; 26(47):12374-83. PubMed ID: 17122062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
